Inovio Pharmaceuticals CEO Joseph Kim at the company’s Sorrento Valley office. The growing company is in development with programs for cancers and infectious diseases.

Inovio Pharmaceuticals CEO Joseph Kim at the company’s Sorrento Valley office. The growing company is in development with programs for cancers and infectious diseases. Photo by Jamie Scott Lytle.

photo

Xinggang Liu, a research associate at Inovio, works in the company’s San Diego lab. Most of Inovio’s 300 employees are in San Diego.

INOVIO PHARMACEUTICALS INC.

CEO: Joseph Kim

Revenue: $42.2 million in 2017 and $35.4 million in 2016

Local employee count: 165

Headquarters: Plymouth Meeting, Pennsylvania

Stock symbol and exchange: INO on Nasdaq

Company description: Inovio’s lead drug candidate is designed to treat without surgery precancerous cervical lesions and cervix infection brought on by HPV, or human papillomavirus. The company has a large drug pipeline.

— Inovio Pharmaceuticals Inc...

Take 1 minute to subscribe and you'll get this story immediately, plus:

Already a subscriber? Sign in

  • 52 weekly issues
  • Subscriber-only digital content every business day, plus full access to SDBJ.com archives
  • Book of Lists — the most comprehensive business resource in San Diego
  • San Diego 500 — influential business leaders you need to know
Yours for only $129